Explore the vast range of titles available.

Polysaccharides are essential macromolecules which almost exist in all living forms, and have important biological functions, they are getting more attention because they exhibit a wide range of biological and pharmacological activities, such as anti-tumour, immunomodulatory, antimicrobial, antioxidant, anticoagulant, antidiabetic, antiviral, and hypoglycemia activities, making them one of the most promising candidates in biomedical and pharmaceutical fields. Polysaccharides can be obtained from many different sources, such as plants, microorganisms, algae, and animals. Due to their physicochemical properties, they are susceptible to physical and chemical modifications leading to enhanced properties, which is the basic concept for their diverse applications in biomedical and pharmaceutical fields. In this review, we will give insight into the most recent updated applications of polysaccharides and their potentialities as alternatives for traditional and conventional therapies. Challenges and limitations for polysaccharides in pharmaceutical utilities are discussed as well.

Design and fabrication of electrochemical energy storage systems with both high energy and power densities as well as long cycling life is of great importance. As one of these systems, Battery‐supercapacitor hybrid device (BSH) is typically constructed with a high‐capacity battery‐type electrode and a high‐rate capacitive electrode, which has attracted enormous attention due to its potential applications in future electric vehicles, smart electric grids, and even miniaturized electronic/optoelectronic devices, etc. With proper design, BSH will provide unique advantages such as high performance, cheapness, safety, and environmental friendliness. This review first addresses the fundamental scientific principle, structure, and possible classification of BSHs, and then reviews the recent advances on various existing and emerging BSHs such as Li‐/Na‐ion BSHs, acidic/alkaline BSHs, BSH with redox electrolytes, and BSH with pseudocapacitive electrode, with the focus on materials and electrochemical performances. Furthermore, recent progresses in BSH devices with specific functionalities of flexibility and transparency, etc. will be highlighted. Finally, the future developing trends and directions as well as the challenges will also be discussed; especially, two conceptual BSHs with aqueous high voltage window and integrated 3D electrode/electrolyte architecture will be proposed. The fundamental scientific principle, structure, and possible classification of battery‐supercapacitor hybrid devices (BSHs), outlining the recent advances on various existing and emerging BSHs, with the focus on materials and electrochemical performances, and finally providing the future developing trends and directions as well as the challenges are addressed in this review.

Due to their unique physicochemical properties, graphene-family nanomaterials (GFNs) are widely used in many fields, especially in biomedical applications. Currently, many studies have investigated the biocompatibility and toxicity of GFNs in vivo and in intro. Generally, GFNs may exert different degrees of toxicity in animals or cell models by following with different administration routes and penetrating through physiological barriers, subsequently being distributed in tissues or located in cells, eventually being excreted out of the bodies. This review collects studies on the toxic effects of GFNs in several organs and cell models. We also point out that various factors determine the toxicity of GFNs including the lateral size, surface structure, functionalization, charge, impurities, aggregations, and corona effect ect. In addition, several typical mechanisms underlying GFN toxicity have been revealed, for instance, physical destruction, oxidative stress, DNA damage, inflammatory response, apoptosis, autophagy, and necrosis. In these mechanisms, (toll-like receptors-) TLR-, transforming growth factor β- (TGF-β-) and tumor necrosis factor-alpha (TNF-α) dependent-pathways are involved in the signalling pathway network, and oxidative stress plays a crucial role in these pathways. In this review, we summarize the available information on regulating factors and the mechanisms of GFNs toxicity, and propose some challenges and suggestions for further investigations of GFNs, with the aim of completing the toxicology mechanisms, and providing suggestions to improve the biological safety of GFNs and facilitate their wide application.

Driven by a small number of niche markets and several decades of application research, fuel cell systems (FCS) are gradually reaching maturity, to the point where many players are questioning the interest and intensity of its deployment in the transport sector in general. This article aims to shed light on this debate from the road transport perspective. It focuses on the description of the fuel cell vehicle (FCV) in order to understand its assets, limitations and current paths of progress. These vehicles are basically hybrid systems combining a fuel cell and a lithium-ion battery, and different architectures are emerging among manufacturers, who adopt very different levels of hybridization. The main opportunity of Fuel Cell Vehicles is clearly their design versatility based on the decoupling of the choice of the number of Fuel Cell modules and hydrogen tanks. This enables manufacturers to meet various specifications using standard products. Upcoming developments will be in line with the crucial advantage of Fuel Cell Vehicles: intensive use in terms of driving range and load capacity. Over the next few decades, long-distance heavy-duty vehicles and fleets of taxis or delivery vehicles will develop based on range extender or mild hybrid architectures and enable the hydrogen sector to mature the technology from niche markets to a large-scale market.

Electrochemical energy storage and conversion systems such as electrochemical capacitors, batteries and fuel cells are considered as the most important technologies proposing environmentally friendly and sustainable solutions to address rapidly growing global energy demands and environmental concerns. Their commercial applications individually or in combination of two or more devices are based on their distinguishing properties e.g., energy/power densities, cyclability and efficiencies. In this review article, we have discussed some of the major electrochemical energy storage and conversion systems and encapsulated their technological advancement in recent years. Fundamental working principles and material compositions of various components such as electrodes and electrolytes have also been discussed. Furthermore, future challenges and perspectives for the applications of these technologies are discussed.

Colorectal cancer (CRC) is one of the deadliest malignancies in the US, ranking fourth after lung, prostate, and breast cancers, respectively, in general populations. It continues to be a menace, and the incidence has been projected to more than double by 2035, especially in underdeveloped countries. This review seeks to provide some insights into the disease progression, currently available treatment options and their challenges, and future perspectives. Searches were conducted in the PubMed search engine in the university’s online library. The keywords were “Colorectal Cancer” AND “disease process” OR “disease mechanisms” OR “Current Treatment” OR “Prospects”. Selection criteria were original articles published primarily during the period of 2013 through 2023. Abstracts, books and documents, and reviews/systematic reviews were filtered out. Of over 490 thousand articles returned, only about 800 met preliminary selection criteria, 200 were reviewed in detail, but 191 met final selection criteria. Fifty-one other articles were used due to cross-referencing. Although recently considered a disease of lifestyle, CRC incidence appears to be rising in countries with low, low–medium, and medium social demographic indices. CRC can affect all parts of the colon and rectum but is more fatal with poor disease outcomes when it is right-sided. The disease progression usually takes between 7–10 years and can be asymptomatic, making early detection and diagnosis difficult. The CRC tumor microenvironment is made up of different types of cells interacting with each other to promote the growth and proliferation of the tumor cells. Significant advancement has been made in the treatment of colorectal cancer. Notable approaches include surgery, chemotherapy, radiation therapy, and cryotherapy. Chemotherapy, including 5-fluorouracil, irinotecan, oxaliplatin, and leucovorin, plays a significant role in the management of CRC that has been diagnosed at advanced stages. Two classes of monoclonal antibody therapies have been approved by the FDA for the treatment of colorectal cancer: the vascular endothelial growth factor (VEGF) inhibitor, e.g., bevacizumab (Avastin®), and the epidermal growth factor receptor (EGFR) inhibitor, e.g., cetuximab (Erbitux®) and panitumumab (Verbitix®). However, many significant problems are still being experienced with these treatments, mainly off-target effects, toxic side effects, and the associated therapeutic failures of small molecular drugs and the rapid loss of efficacy of mAb therapies. Other novel delivery strategies continue to be investigated, including ligand-based targeting of CRC cells.

This paper provides an in-depth review of the current state and future potential of hydrogen fuel cell vehicles (HFCVs). The urgency for more eco-friendly and efficient alternatives to fossil-fuel-powered vehicles underlines the necessity of HFCVs, which utilize hydrogen gas to power an onboard electric motor, producing only water vapor and heat. Despite their impressive energy efficiency ratio (EER), higher power-to-weight ratio, and substantial emissions reduction potential, the widespread implementation of HFCVs is presently hindered by several technical and infrastructural challenges. These include high manufacturing costs, the relatively low energy density of hydrogen, safety concerns, fuel cell durability issues, insufficient hydrogen refueling infrastructure, and the complexities of hydrogen storage and transportation. Nevertheless, technological advancements and potential policy interventions offer promising prospects for HFCVs, suggesting they could become a vital component of sustainable transportation in the future.

The declining trends in microbial metabolite and natural products research and the refocusing of this research area are discussed. Renewing natural products research requires inexhaustible natural resources, as well as new genetic techniques and microbial sources, including endophytic microbes. The numbers of known bioactive metabolites are summarized according to their microbiological origin, biological activities and chemical structures. Synthetic and natural product-based libraries are also compared. Importantly, the wide range of microbial metabolite bioactivities, future trends and the importance of prioritizing natural products over synthetic compounds are emphasized.

Ultra-high-performance concrete (UHPC) is a form of cementitious composite that has been the most innovative product in concrete technology over the last three decades. Ultra-high-performance concrete has been broadly employed for the design of numerous forms of construction owing to its excellent mechanical characteristics and durability, and studies on its behavior have grown fast in the last decades. While the utilization of ultra-high-performance concrete in bridge engineering (BE) is limited owing to its high costs, little is recognized about the utilization of UHPC in various BE elements. As a result of these issues, a comprehensive review of the current UHPC development trends should be conducted to determine its present state and perspective. This study presents a review of the state-of-the-art UHPC applications in BE. This review also discusses the current status, limitations, challenges, and areas for the further investigation of UHPC in BE. The aim of this research to help various construction stakeholders understand the distinctive characteristics, benefits, and barriers to the broad utilization of ultra-high-performance concrete applications. The understanding of UHPC will aid in increasing its entire market share in both the national and worldwide building sectors.

The latest pre-production vehicles on the market show that the major technical challenges posed by integrating a fuel cell system (FCS) within a vehicle—compactness, safety, autonomy, reliability, cold starting—have been met. Regarding the ongoing maturity of fuel cell systems dedicated to road transport, the present article examines the advances still needed to move from a functional but niche product to a mainstream consumer product. It seeks to address difficulties not covered by more traditional innovation approaches. At least in long-distance heavy-duty vehicles, fuel cell vehicles (FCVs) are going to play a key role in the path to zero-emissions in one or two decades. Hence the present study also addresses the structuring elements of the complete chain: the latter includes the production, storage and distribution of hydrogen. Green hydrogen appears to be one of the potential uses of renewable energies. The greener the electricity is, the greater the advantage for hydrogen since it permits to economically store large energy quantities on seasonal rhythms. Moreover, natural hydrogen might also become an economic reality pushing the fuel cell vehicle to be a competitive and environmentally friendly alternative to the battery electric vehicle. Based on its own functional benefits for on board systems, hydrogen in combination with the fuel cell will achieve a large-scale use of hydrogen in road transport, as soon as renewable energies become more widespread. Its market will expand from large driving range and heavy load vehicles.